ICG navigation surgery study

Efficacy of ICG Navigation Robotic Surgery for Esophageal and Gastric Cancers

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031220636

Enrollment

Registered

2023-02-13

Start date

2023-02-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric or esophageal cancer

Interventions

To inject ICG at 4 sites around the lesion 1 to 3 days before surgery to determine the dissection line while observing ICG fluorescence during surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with gastric or esophageal cancer undergoing robotic surgery

Exclusion criteria

Exclusion criteria: judged uneligible by the research director

Design outcomes

Primary

Measure	Time frame
Distance between the tumor edge andresection margin	—

Secondary

Measure	Time frame
operative time estimated blood loss postoperative complication rate the number of lymph node dissection local recurrence rate	—

Contacts

Public ContactShunichi Ito

Tokyo Women's Medical University Hospital

ito.shunichi@twmu.ac.jp+81-3-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026